1-3 of 3
Susanne Rötzer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Bone Resorption Marker Serum-ICTP and the Circulating Proteasome Levels Separate ISS-Stages 1–3 and Are the Most Powerful Prognostic Factors for Overall Survival in Newly Diagnosed Symptomatic Multiple Myeloma.

Christian Jakob, MD, Peter Liebisch, MD, Karl Egerer, MD, Jan Sterz, MD, Martin Kaiser, MD, Susanne Rötzer, MD, Ulrike Heider, MD, Jessica Rademacher, MD, Claudia Fleissner, MD, Peter M. Kloetzel, PhD, Evangelos Terpos, MD, Orhan Sezer, MD
Journal: Blood
Blood (2007) 110 (11): 1475.
https://doi.org/10.1182/blood.V110.11.1475.1475
Published: 2007
Journal Articles

Serum Concentrations of DKK-1 Correlate with the Extent of Bone Disease in Multiple Myeloma.

Martin Kaiser, MD, Maren Mieth, PhD, Peter Liebisch, MD, PhD, Susanne Rötzer, Christian Jakob, MD, Claudia Fleissner, MD, Edgar Braendle, MD, PhD, David Stover, PhD, Malte Peters, MD, PhD, Orhan Sezer, MD, PhD, Ulrike Heider, MD
Journal: Blood
Blood (2007) 110 (11): 3518.
https://doi.org/10.1182/blood.V110.11.3518.3518
Published: 2007
Journal Articles

The Proteasome Inhibitor BSc2118 Causes Growth Inhibition, Cell Cycle Arrest and Cyclin D1 Degradation in Mantle Cell Lymphoma Cell Lines.

Christian Jakob, MD, Jan Sterz, MD, Ivana von Metzler, MD, Ulrike Kuckelkorn, PhD, Hannes A. Braun, PhD, Susanne Rötzer, MD, Martin Kaiser, MD, Ulrike Heider, MD, Jessica Rademacher, MD, Peter M. Kloetzel, PhD, Orhan Sezer, MD
Journal: Blood
Blood (2007) 110 (11): 1401.
https://doi.org/10.1182/blood.V110.11.1401.1401
Published: 2007